Literature DB >> 14208932

TRANSMEMBRANE ACTION POTENTIALS AND CONTRACTIONS OF HUMAN ATRIAL MUSCLE.

W SLEATOR, T DEGUBAREFF.   

Abstract

Entities:  

Keywords:  ACETYLCHOLINE; ADOLESCENCE; AORTIC VALVE STENOSIS; CELL MEMBRANE; CHILD; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; EPINEPHRINE; EXPERIMENTAL LAB STUDY; GERIATRICS; HEART; HEART DISEASES; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; INFANT; MITRAL VALVE STENOSIS; NOREPINEPHRINE; PHARMACOLOGY; PHYSIOLOGY; PULMONARY VALVE STENOSIS; TEMPERATURE; TETRALOGY OF FALLOT

Mesh：

Substances：

Year:  1964        PMID： 14208932     DOI： 10.1152/ajplegacy.1964.206.5.1000

Source DB:  PubMed          Journal:  Am J Physiol        ISSN： 0002-9513


× No keyword cloud information.
  7 in total

1.  Effect of ryanodine on myocardial calcium.

Authors:  M Frank; W W Sleator
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Development of human foetal inotropic responses to catecholamines.

Authors:  D J Coltart; B A Spilker
Journal:  Experientia       Date:  1972-05-15

3.  An electrophysiological study of human foetal cardiac muscle.

Authors:  D J Coltart; B A Spilker; S J Meldrum
Journal:  Experientia       Date:  1971-07

4.  Electrical activity of a single fibre of the human embryonic heart.

Authors:  W Tuganowski; A Cekański
Journal:  Pflugers Arch       Date:  1971       Impact factor: 3.657

Review 5.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

6.  The effect of aminosteroid, ORG 6001, on hypothermia induced ventricular fibrillation in the cat.

Authors:  K A Kane; F M McDonald; J R Parratt
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

7.  Functional role of cholinoceptors and purinoceptors in human isolated atrial and ventricular heart muscle.

Authors:  H Jakob; H Oelert; J Rupp; H Nawrath
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.